[PDF][PDF] 新冠肺炎COVID-19 藥物發展
田至峰， 蔡宛庭， 蔡瑋祥， 余冠儀 - 感染控制雜誌, 2023 - cdc.gov.tw
… Lenze EJ, Mattar C, Zorumski CF, et al: Fluvoxamine vs placebo and clinical deterioration
in outpatients with symptomatic COVID-19: A Randomized Clinical Trial. JAMA 2020;324(22): …
in outpatients with symptomatic COVID-19: A Randomized Clinical Trial. JAMA 2020;324(22): …
[PDF][PDF] 新型冠状病毒肺炎药物引起获得性长QT 综合征的研究进展
傅银， 廉姜芳 - 心电与循环 - xdyxh.com
… Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID19:
a randomized clinical trial [J]. JAMA, 2020, 324 (22): 22922300. DOI: 10.1001/jama.…
a randomized clinical trial [J]. JAMA, 2020, 324 (22): 22922300. DOI: 10.1001/jama.…